Published in J Clin Oncol on February 22, 2005
Patterns of complementary and alternative medicine use amongst outpatients in Tokyo, Japan. BMC Complement Altern Med (2008) 1.44
The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis. PLoS One (2013) 1.34
Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist (2012) 1.34
High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol (2005) 1.18
Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer (2011) 1.16
ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World J Gastroenterol (2006) 1.07
First nationwide attitude survey of Japanese physicians on the use of traditional Japanese medicine (kampo) in cancer treatment. Evid Based Complement Alternat Med (2012) 0.99
The use of Complementary and Alternative Medicine by cancer patients. Int Semin Surg Oncol (2007) 0.95
Use of Chinese medicine by cancer patients: a review of surveys. Chin Med (2011) 0.95
A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma. Sci Rep (2014) 0.94
Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians. Evid Based Complement Alternat Med (2012) 0.92
Integrative oncology: best of both worlds-theoretical, practical, and research issues. Evid Based Complement Alternat Med (2013) 0.91
Inappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan. Nutrients (2014) 0.91
Emerging roles of propolis: antioxidant, cardioprotective, and antiangiogenic actions. Evid Based Complement Alternat Med (2013) 0.90
Complementary and alternative medicine use by visitors to rural Japanese family medicine clinics: results from the international complementary and alternative medicine survey. BMC Complement Altern Med (2014) 0.89
Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey. Chin Med (2009) 0.88
Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Bone Marrow Transplant (2012) 0.88
Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. Cancer Res Treat (2008) 0.86
Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer (2008) 0.85
Use of chinese herb medicine in cancer patients: a survey in southwestern china. Evid Based Complement Alternat Med (2012) 0.85
Complementary or alternative medicine in cancer care-myths and realities. Nat Rev Clin Oncol (2013) 0.85
Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents. Evid Based Complement Alternat Med (2013) 0.83
Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines. Int J Clin Oncol (2011) 0.83
Brazilian propolis: a natural product that improved the fungicidal activity by blood phagocytes. Biomed Res Int (2012) 0.82
Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patients. BMC Complement Altern Med (2014) 0.82
Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission. Evid Based Complement Alternat Med (2011) 0.81
Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team. Support Care Cancer (2007) 0.81
Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Sci Rep (2016) 0.81
The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional survey. BMC Complement Altern Med (2012) 0.80
Biologically based therapies are commonly self-prescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms. Support Care Cancer (2013) 0.80
Complementary and alternative medicine use and disclosure amongst Australian radiotherapy patients. Support Care Cancer (2014) 0.80
Complementary and alternative medicine use among patients with thoracic malignancies. Support Care Cancer (2014) 0.79
Use of complementary and alternative medicine by patients with hematological diseases experience at a university hospital in northeast Mexico. Rev Bras Hematol Hemoter (2012) 0.79
Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014. BMC Complement Altern Med (2016) 0.79
Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements. BMC Complement Altern Med (2014) 0.78
Consultation clinics for complementary and alternative medicine at Japanese university hospitals: An analysis at Tokushima University Hospital. Exp Ther Med (2010) 0.78
Complementary and alternative medicine usage in cancer patients in southeast of Turkey. Afr J Tradit Complement Altern Med (2012) 0.78
Acupuncture and herbal medicine for cancer patients. Evid Based Complement Alternat Med (2013) 0.77
Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea. Evid Based Complement Alternat Med (2012) 0.77
Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study. J Altern Complement Med (2015) 0.77
Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan. Cancer Nurs (2015) 0.76
Concomitant use of dietary supplements and medicines in patients due to miscommunication with physicians in Japan. Nutrients (2015) 0.76
Using Basic Science to Develop an Innovative Program in Complementary and Alternative Medicine. J Int Assoc Med Sci Educ (2010) 0.76
Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study. J Altern Complement Med (2017) 0.75
Soliciting an herbal medicine and supplement use history at hospice admission. J Palliat Med (2010) 0.75
The influence of chlorella and its hot water extract supplementation on quality of life in patients with breast cancer. Evid Based Complement Alternat Med (2014) 0.75
Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany. PLoS One (2016) 0.75
Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study. J Tradit Complement Med (2015) 0.75
Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey. BMC Complement Altern Med (2017) 0.75
The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo. Front Pharmacol (2015) 0.75
Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK. Cancer Immunol Immunother (2013) 0.75
A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer. BMJ Open (2014) 0.75
National survey of China's oncologists' knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine. Oncotarget (2017) 0.75
HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY. Afr J Tradit Complement Altern Med (2017) 0.75
Complementary therapy use in metropolitan and regional Australian radiotherapy centres; do patients report effective outcomes? Support Care Cancer (2015) 0.75
The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer "fighting against cancer". Support Care Cancer (2014) 0.75
Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey. J Cancer Surviv (2017) 0.75
"We make choices we think are going to save us": Debate and stance identification for online breast cancer CAM discussions. Proc Int World Wide Web Conf (2017) 0.75
C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol (2006) 3.53
CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol (2006) 3.39
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol (2008) 3.27
Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol (2005) 3.09
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer (2007) 2.43
Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int (2008) 2.39
Effects of a programme of interventions on regional comprehensive palliative care for patients with cancer: a mixed-methods study. Lancet Oncol (2013) 2.34
Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol (2002) 2.18
A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol (2008) 2.01
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol (2006) 1.88
Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer (2003) 1.82
Focal ground-glass opacity detected by low-dose helical CT. Chest (2002) 1.79
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin. Cancer Sci (2010) 1.72
Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol (2003) 1.58
Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology (2002) 1.58
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun (2008) 1.56
Virus-associated hemophagocytic syndrome in an international traveler as a differential diagnosis of SARS. Intern Med (2005) 1.54
Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol (2011) 1.53
A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer. J Thorac Oncol (2008) 1.53
Pulmonary angioplastic procedure for lung cancer surgery. Gen Thorac Cardiovasc Surg (2010) 1.51
Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. Gen Hosp Psychiatry (2009) 1.47
Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys (2012) 1.43
Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. Lung Cancer (2006) 1.43
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. Int J Clin Oncol (2005) 1.42
Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol (2009) 1.38
Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med (2008) 1.36
Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer. Cancer Sci (2006) 1.31
Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol (2007) 1.28
Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 1.27
Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy. Lung Cancer (2008) 1.27
Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun (2005) 1.26
Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol (2004) 1.22
A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group. Breast Cancer (2004) 1.22
Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg (2003) 1.20
Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol (2009) 1.19
Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg (2004) 1.18
Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol Ther (2003) 1.18
Epidermal inclusion cyst of the breast. Breast Cancer (2007) 1.17
IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter (2008) 1.17
Changes in Attitudes of Japanese Doctors toward Complementary and Alternative Medicine-Comparison of Surveys in 1999 and 2005 in Kyoto. Evid Based Complement Alternat Med (2011) 1.16
Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer (2003) 1.14
Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr (2004) 1.13
Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol (2010) 1.13
Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg (2005) 1.12
Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors. J Virol (2004) 1.12
Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. Radiother Oncol (2010) 1.12
Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung. Clin Cancer Res (2002) 1.10
Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection. J Interferon Cytokine Res (2002) 1.09
Suicidality in terminally ill Japanese patients with cancer. Cancer (2004) 1.08
CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer. Oncol Rep (2005) 1.05
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group. Breast Cancer Res Treat (2009) 1.05
Immunological and Psychological Benefits of Aromatherapy Massage. Evid Based Complement Alternat Med (2005) 1.04
Burnout and psychiatric morbidity among physicians engaged in end-of-life care for cancer patients: a cross-sectional nationwide survey in Japan. Psychooncology (2007) 1.04
Involvement of Runx1 in the down-regulation of fetal liver kinase-1 expression during transition of endothelial cells to hematopoietic cells. Blood (2005) 1.03
Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer (2002) 1.03
Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol Immunol (2004) 1.03
Providing palliative care for cancer patients: the views and exposure of community general practitioners and district nurses in Japan. J Pain Symptom Manage (2011) 1.03
Preferred place of care and place of death of the general public and cancer patients in Japan. Support Care Cancer (2012) 1.03
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Cancer Chemother Pharmacol (2010) 1.02
Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. Cancer Res (2009) 1.02
Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer. Cancer Chemother Pharmacol (2007) 1.02
Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004. J Thorac Oncol (2012) 1.02
Hemogenic and nonhemogenic endothelium can be distinguished by the activity of fetal liver kinase (Flk)-1 promoter/enhancer during mouse embryogenesis. Blood (2002) 1.01
Development of an Impact Thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Manage (2005) 1.01
Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells. Arterioscler Thromb Vasc Biol (2009) 1.01
Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer. Anticancer Res (2010) 0.99
Cancer patients' reluctance to disclose their emotional distress to their physicians: a study of Japanese patients with lung cancer. Psychooncology (2008) 0.99
Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J Interferon Cytokine Res (2004) 0.99
No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat (2005) 0.99
Psychological distress experienced by families of cancer patients: preliminary findings from psychiatric consultation of a Cancer Center Hospital. Jpn J Clin Oncol (2006) 0.97
Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med (2007) 0.96
Nodular pseudoangiomatous stromal hyperplasia of mammary stroma in a case showing rapid tumor growth. Breast Cancer (2005) 0.96
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks. Invest New Drugs (2011) 0.96
Prefrontal cortex and amygdala volume in first minor or major depressive episode after cancer diagnosis. Biol Psychiatry (2005) 0.96
Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study. J Thorac Oncol (2010) 0.96
Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Lung Cancer (2007) 0.96
IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice. J Immunol (2007) 0.96
Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) study. Am J Hosp Palliat Care (2008) 0.96
IL-21 administration into the nostril alleviates murine allergic rhinitis. J Immunol (2007) 0.95
Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. J Bone Miner Metab (2009) 0.95
Contrast-enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer. Jpn J Clin Oncol (2008) 0.95
Quantitative classification based on CT histogram analysis of non-small cell lung cancer: correlation with histopathological characteristics and recurrence-free survival. Med Phys (2012) 0.95
A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence. Support Care Cancer (2004) 0.95
Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database. J Thorac Oncol (2013) 0.94
A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients. Int J Clin Oncol (2012) 0.94
Metastatic Breast Cancer to the Stomach Resembling Early Gastric Cancer. Case Rep Oncol (2010) 0.94
CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1. Cancer Sci (2008) 0.94
Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe. Med Phys (2008) 0.94
UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer. Cancer Chemother Pharmacol (2010) 0.93
Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer. J Thorac Oncol (2008) 0.93
Hydrostatic pressure induces apoptosis of chondrocytes cultured in alginate beads. J Orthop Res (2006) 0.93
First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study. Breast Cancer Res Treat (2011) 0.93
Measurement of interfraction variations in position and size of target volumes in stereotactic body radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys (2009) 0.93
Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia. Cancer (2002) 0.92
Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma. Lung Cancer (2010) 0.92